Matches in SemOpenAlex for { <https://semopenalex.org/work/W4241898689> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4241898689 endingPage "8" @default.
- W4241898689 startingPage "1" @default.
- W4241898689 abstract "The effect of the group II metabotropic receptor agonist (−)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), on basal and phencyclidine-induced dopamine efflux were measured in the shell and core subdivisions of the nucleus accumbens—regions which are associated with limbic and motor functions, respectively. Extracellular levels of dopamine were measured using microdialysis in conscious animals, and LY379268 was delivered locally by inclusion in the artificial cerebrospinal fluid (aCSF) flowing through the microdialysis probe. Local administration of LY379268 in the concentration range 10 nM–10 μM reduced basal levels of dopamine in the nucleus accumbens shell, whilst having no effect in the nucleus accumbens core. In the nucleus accumbens shell, basal levels were reduced to approximately 60% compared to the pre-injection control, with a maximal reduction occurring at concentrations of LY379268 ≥100 nM. The response to LY379268 (100 nM) was reversible, with levels returning to baseline following its removal from the aCSF. In a separate experiment, local perfusion of the nucleus accumbens shell with LY379268 (at both 1 and 10 μM) reduced the magnitude of the response to a subsequent systemic administration of phencyclidine (5 mg/kg i.p.). The reduction in the peak dopamine response was only evident with doses of LY379268 that also reduced basal dopamine efflux—LY379268 being ineffective against PCP at 10 nM. However, in animals pre-treated with LY379268 at 1 or 10 μM, PCP still evoked a dopamine response, and in these animals the relative extent of the response was not significantly different between the respective treatment groups. In contrast, in the nucleus accumbens core the magnitude of the dopamine response to PCP was unaffected by local application of LY379268 (at 1 or 10 μM). Our data suggest that within the nucleus accumbens, there exists a distinct regional difference in the control of dopamine release by group II mGluRs, with the nucleus accumbens shell being preferentially affected. Moreover, the selective action of LY379268 on dopamine levels in the nucleus accumbens shell may have implications for the potential antipsychotic activity of group II mGluR agonists." @default.
- W4241898689 created "2022-05-12" @default.
- W4241898689 creator A5085263987 @default.
- W4241898689 date "2004-07-01" @default.
- W4241898689 modified "2023-09-30" @default.
- W4241898689 title "Selective action of ($minus;)-2-oxa-4-aminobicyclo63.1.09hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell" @default.
- W4241898689 doi "https://doi.org/10.1016/s0028-3908(04)00052-8" @default.
- W4241898689 hasPublicationYear "2004" @default.
- W4241898689 type Work @default.
- W4241898689 citedByCount "0" @default.
- W4241898689 crossrefType "journal-article" @default.
- W4241898689 hasAuthorship W4241898689A5085263987 @default.
- W4241898689 hasConcept C126322002 @default.
- W4241898689 hasConcept C134018914 @default.
- W4241898689 hasConcept C170493617 @default.
- W4241898689 hasConcept C185592680 @default.
- W4241898689 hasConcept C2776552330 @default.
- W4241898689 hasConcept C2778187257 @default.
- W4241898689 hasConcept C2778938600 @default.
- W4241898689 hasConcept C2779305214 @default.
- W4241898689 hasConcept C2780278869 @default.
- W4241898689 hasConcept C50156730 @default.
- W4241898689 hasConcept C513476851 @default.
- W4241898689 hasConcept C529278444 @default.
- W4241898689 hasConcept C55493867 @default.
- W4241898689 hasConcept C71924100 @default.
- W4241898689 hasConcept C86803240 @default.
- W4241898689 hasConceptScore W4241898689C126322002 @default.
- W4241898689 hasConceptScore W4241898689C134018914 @default.
- W4241898689 hasConceptScore W4241898689C170493617 @default.
- W4241898689 hasConceptScore W4241898689C185592680 @default.
- W4241898689 hasConceptScore W4241898689C2776552330 @default.
- W4241898689 hasConceptScore W4241898689C2778187257 @default.
- W4241898689 hasConceptScore W4241898689C2778938600 @default.
- W4241898689 hasConceptScore W4241898689C2779305214 @default.
- W4241898689 hasConceptScore W4241898689C2780278869 @default.
- W4241898689 hasConceptScore W4241898689C50156730 @default.
- W4241898689 hasConceptScore W4241898689C513476851 @default.
- W4241898689 hasConceptScore W4241898689C529278444 @default.
- W4241898689 hasConceptScore W4241898689C55493867 @default.
- W4241898689 hasConceptScore W4241898689C71924100 @default.
- W4241898689 hasConceptScore W4241898689C86803240 @default.
- W4241898689 hasIssue "1" @default.
- W4241898689 hasLocation W42418986891 @default.
- W4241898689 hasOpenAccess W4241898689 @default.
- W4241898689 hasPrimaryLocation W42418986891 @default.
- W4241898689 hasRelatedWork W1964647305 @default.
- W4241898689 hasRelatedWork W1967987600 @default.
- W4241898689 hasRelatedWork W1987976668 @default.
- W4241898689 hasRelatedWork W1998106245 @default.
- W4241898689 hasRelatedWork W2022203440 @default.
- W4241898689 hasRelatedWork W2055119063 @default.
- W4241898689 hasRelatedWork W2059743894 @default.
- W4241898689 hasRelatedWork W2087908630 @default.
- W4241898689 hasRelatedWork W2091884605 @default.
- W4241898689 hasRelatedWork W2171870758 @default.
- W4241898689 hasVolume "47" @default.
- W4241898689 isParatext "false" @default.
- W4241898689 isRetracted "false" @default.
- W4241898689 workType "article" @default.